Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-15,000
Closed -$1.2M 97
2022
Q2
$1.2M Sell
15,000
-5,000
-25% -$506K 0.05% 70
2022
Q1
$2.26M Hold
20,000
0.05% 63
2021
Q4
$2.31M Buy
+20,000
New +$2.15M 0.06% 58
2019
Q1
Sell
-19,000
Closed -$978K 95
2018
Q4
$978K Buy
+19,000
New +$1.22M 0.03% 66
2018
Q3
Sell
-13,000
Closed -$903K 78
2018
Q2
$903K Hold
13,000
0.03% 62
2018
Q1
$828K Sell
13,000
-5,000
-28% -$367K 0.04% 55
2017
Q4
$1.3M Sell
18,000
-32,000
-64% -$1.97M 0.05% 43
2017
Q3
$2.97M Buy
+50,000
New +$3.01M 0.13% 32

Other funds holding DVA

Ruffer LLP's DVA Position: Q3 2022 in Review

Ruffer LLP sold out of DaVita (DVA) in Q3 2022, closing a stake of 15,000 shares — an estimated $1.2M sold.

Ruffer LLP first reported a position in DVA in Q3 2017 and held it in 8 quarters. The position peaked at $2.97M in Q3 2017. 441 funds tracked by Wall St. Rank hold DVA as of Q3 2022.

  • Ruffer LLP reported no remaining DaVita position as of Q3 2022 after selling out during the quarter.
  • Ruffer LLP sold 15,000 DaVita shares in Q3 2022, an estimated $1.2M.
  • Ruffer LLP first reported a position in DaVita in Q3 2017 and held it in 8 quarters.
  • Ruffer LLP's DaVita position peaked at $2.97M in Q3 2017.
  • 441 funds tracked by Wall St. Rank held DaVita as of Q3 2022.

Based on Ruffer LLP's 13F filing for Q3 2022, filed 10 Nov 2022.